We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+11.11%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$218B
AUM Growth
-$5.41B
Cap. Flow
-$25.1B
Cap. Flow %
-11.51%
Top 10 Hldgs %
47.1%
Holding
5,603
New
345
Increased
2,379
Reduced
1,667
Closed
541

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.82B
2
AAPL icon
Apple
AAPL
+$1.62B
3
UNH icon
UnitedHealth
UNH
+$1.03B
4
XOM icon
ExxonMobil
XOM
+$869M
5
TSLA icon
Tesla
TSLA
+$701M

Sector Composition

Rank Sector Weight
1 Technology 12.19%
2 Consumer Discretionary 5.03%
3 Healthcare 4.78%
4 Financials 4.74%
5 Communication Services 2.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APM
4826
DELISTED
Aptorum Group
APM
$32 ﹤0.01%
+12
New +$48
EVOJW
4827
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$32 ﹤0.01%
200
SYRE icon
4828
Spyre Therapeutics
SYRE
$8.48B
$29 ﹤0.01%
4
EWG icon
4829
iShares MSCI Germany ETF
EWG
$1.59B
$28 ﹤0.01%
1
GBLI icon
4830
Global Indemnity Group
GBLI
$402M
$28 ﹤0.01%
1
JWSM.WS
4831
DELISTED
Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
JWSM.WS
$27 ﹤0.01%
250
UPH
4832
DELISTED
UpHealth, Inc.
UPH
$25 ﹤0.01%
+17
New +$38
SABS icon
4833
SAB Biotherapeutics
SABS
$263M
$24 ﹤0.01%
+5
New +$32
XMAX
4834
XMAX Inc
XMAX
$552M
$21 ﹤0.01%
7
SVRN
4835
OceanPal Inc
SVRN
$11.1M
0
YCBD icon
4836
cbdMD
YCBD
$5.46M
0
LSTA icon
4837
Lisata Therapeutics
LSTA
$9.2M
$19 ﹤0.01%
6
+2
+50% +$7
MOMO
4838
Hello Group
MOMO
$879M
$18 ﹤0.01%
2
-265,000
-100% -$2.53M
ENLT icon
4839
Enlight Renewable Energy
ENLT
$11.8B
$17 ﹤0.01%
+1
New +$17
PULM icon
4840
Pulmatrix
PULM
$6.17M
$15 ﹤0.01%
5
MOR
4841
DELISTED
MorphoSys AG American Depositary Shares
MOR
$12 ﹤0.01%
3
-9
-75% -$40
GGB icon
4842
Gerdau
GGB
$9.76B
$10 ﹤0.01%
2
-312,144
-100% -$1.4M
APLT
4843
DELISTED
Applied Therapeutics
APLT
$9 ﹤0.01%
+11
New +$11
ARHS icon
4844
Arhaus
ARHS
$1.04B
$8 ﹤0.01%
1
-41,299
-100% -$499K
TCDA
4845
DELISTED
Tricida, Inc. Common Stock
TCDA
$8 ﹤0.01%
753
-8,941
-92% -$1.4K
SHCO
4846
DELISTED
Soho House & Co
SHCO
$7 ﹤0.01%
1
VRN
4847
DELISTED
Veren
VRN
$7 ﹤0.01%
1
MUFG icon
4848
Mitsubishi UFJ Financial
MUFG
$254B
$6 ﹤0.01%
+1
New +$7
NCMI icon
4849
National CineMedia
NCMI
$369M
$5 ﹤0.01%
+4
New +$9
SWVLW icon
4850
Swvl Holdings Corp Warrant
SWVLW
$139K
$5 ﹤0.01%
238

Similar funds

Barclays's Q1 2023 Portfolio in Review

As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.

  • Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
  • Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
  • Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
  • Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
  • Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
  • Barclays opened 345 new positions and closed 541 in Q1 2023.
  • Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.

Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.